@article{aed79efe107d4fbf8ce2049679a3d333,
title = "Unraveling the Risk of Peripheral Artery Disease",
keywords = "Editorials, peripheral arterial disease",
author = "Joshi, {Parag H.} and Martin, {Seth S.}",
note = "Funding Information: Dr Joshi receives consulting income from Regeneron; institutional grant support from Pfizer, Regeneron/Sanofi, AstraZeneca, and GlaxoSmithKline; and funding from the American Heart Association. Dr Martin receives personal fees for serving on scientific advisory boards for Amgen, Sanofi/Regeneron, Quest Diagnostics, and Akcea Therapeutics, as well as grants and research support from the PJ Schafer Cardiovascular Research Fund, David and June Trone Family Foundation, American Heart Association, Aetna Foundation, Maryland Innovation Initiative, Nokia, iHealth, Google, and Apple. In addition, he reports having patent applications pending.",
year = "2018",
month = nov,
day = "20",
doi = "10.1161/CIRCULATIONAHA.118.036347",
language = "English (US)",
volume = "138",
pages = "2342--2344",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "21",
}